FIELD: chemical-pharmaceutical industry, immunology. SUBSTANCE: invention proposes to use dipeptide L-lysyl-L-glutamic acid as agent showing immunomodulating activity. EFFECT: enhanced effectiveness of agent proposed. 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT STIMULATING REPARATIVE PROCESSES AND METHOD OF ITS USE | 1998 |
|
RU2139085C1 |
| PEPTIDE POSSESSING IMMUNOGEROPROTECTIVE EFFECT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 |
|
RU2301074C1 |
| AGENT ELICITING IMMUNOSTIMULATING ACTIVITY | 2000 |
|
RU2177803C1 |
| PREPARATION STIMULATING THE DIFFERENTIATION OF T-LYMPHOCYTES | 2001 |
|
RU2188032C1 |
| AGENT INHIBITING ANGIOGENESIS IN VISUAL ORGAN DISEASE | 2001 |
|
RU2177801C1 |
| METHOD OF ESTIMATION OF BIOLOGICAL ACTIVITY OF THYMUS PREPARATION | 1985 |
|
SU1441928A1 |
| TREATMENT-AND-PROPHYLACTIC AGENT FOR SKIN CARE | 2000 |
|
RU2161974C1 |
| TETRAPEPTIDE REGULATING GLUCOSE LEVEL IN DIABETES MELLITUS, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS APPLYING | 2003 |
|
RU2242241C1 |
| METHOD AND COMPOSITION USED FOR ACTIVATION OF TELOMERASE | 2015 |
|
RU2593586C1 |
| PHARMACEUTICAL COMPOSITION BASED ON PEPTIDE REGULATING DISTURBANCES OF ANGIOGENESIS, AND WAY OF ITS APPLICATION | 2007 |
|
RU2363488C1 |
